Guardant Health, Inc. (GH): Price and Financial Metrics
GH Price/Volume Stats
| Current price | $47.76 | 52-week high | $52.92 |
| Prev. close | $45.79 | 52-week low | $20.14 |
| Day low | $45.44 | Volume | 2,691,300 |
| Day high | $48.05 | Avg. volume | 2,344,664 |
| 50-day MA | $42.98 | Dividend yield | N/A |
| 200-day MA | $35.51 | Market Cap | 5.92B |
GH Stock Price Chart Interactive Chart >
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
GH Price Returns
| 1-mo | 13.90% |
| 3-mo | 21.46% |
| 6-mo | 29.54% |
| 1-year | 53.13% |
| 3-year | 22.40% |
| 5-year | -42.61% |
| YTD | 56.33% |
| 2024 | 12.94% |
| 2023 | -0.55% |
| 2022 | -72.81% |
| 2021 | -22.39% |
| 2020 | 64.93% |
Continue Researching GH
Want to do more research on Guardant Health Inc's stock and its price? Try the links below:Guardant Health Inc (GH) Stock Price | Nasdaq
Guardant Health Inc (GH) Stock Quote, History and News - Yahoo Finance
Guardant Health Inc (GH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...